Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 24563-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- NCAPG antibody
- Antibody type
- Polyclonal
- Description
- NCAPG antibody (Cat. #24563-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification.
Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance.
NCAPG is transcriptionally regulated by CBX3 and activates the Wnt/β-catenin signaling pathway to promote proliferation and the cell cycle and inhibit apoptosis in colorectal cancer.
Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis.
NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma.
NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN.
Adipose-derived mesenchymal stem cells differentiate into heterogeneous cancer-associated fibroblasts in a stroma-rich xenograft model.
NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer.
Jia Y, Yang J, Chen Y, Liu Y, Jin Y, Wang C, Gong B, Zhao Q
International journal of molecular sciences 2023 Oct 6;24(19)
International journal of molecular sciences 2023 Oct 6;24(19)
Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance.
Zheng K, Hai Y, Xi Y, Zhang Y, Liu Z, Chen W, Hu X, Zou X, Hao J
Journal of translational medicine 2023 Nov 7;21(1):789
Journal of translational medicine 2023 Nov 7;21(1):789
NCAPG is transcriptionally regulated by CBX3 and activates the Wnt/β-catenin signaling pathway to promote proliferation and the cell cycle and inhibit apoptosis in colorectal cancer.
Yang H, Pu L, Li R, Zhu R
Journal of gastrointestinal oncology 2023 Apr 29;14(2):900-912
Journal of gastrointestinal oncology 2023 Apr 29;14(2):900-912
Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis.
Mengyan X, Kun D, Xinming J, Yutian W, Yongqian S
Frontiers in pharmacology 2022;13:997842
Frontiers in pharmacology 2022;13:997842
NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma.
Zheng G, Han T, Hu X, Yang Z, Wang J, Wen Z, Li H, Wang H
Frontiers in oncology 2022;12:770628
Frontiers in oncology 2022;12:770628
NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN.
Zhang R, Ai J, Wang J, Sun C, Lu H, He A, Li M, Liao Y, Lei J, Zhou F, Wu L, Liao W
Journal of translational medicine 2022 Jul 21;20(1):325
Journal of translational medicine 2022 Jul 21;20(1):325
Adipose-derived mesenchymal stem cells differentiate into heterogeneous cancer-associated fibroblasts in a stroma-rich xenograft model.
Miyazaki Y, Oda T, Inagaki Y, Kushige H, Saito Y, Mori N, Takayama Y, Kumagai Y, Mitsuyama T, Kida YS
Scientific reports 2021 Feb 25;11(1):4690
Scientific reports 2021 Feb 25;11(1):4690
NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer.
Jiang L, Ren L, Chen H, Pan J, Zhang Z, Kuang X, Chen X, Bao W, Lin C, Zhou Z, Huang D, Yang J, Huang H, Wang L, Hou N, Song L
Cell death & disease 2020 Jul 18;11(7):547
Cell death & disease 2020 Jul 18;11(7):547
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HEK-293 cells were subjected to SDS PAGE followed by western blot with 24563-1-AP( NCAPG Antibody) at dilution of 1:1500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The NCAPG antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human NCAPG. This antibody recognizes human antigen. The NCAPG antibody has been validated for the following applications: ELISA, WB, IHC analysis.
